Edwyn
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $3,129 | $3,328 | $7,320 | $9,617 | $5,378 |
| Gross Profit | $995 | $998 | $3,075 | $1,186 | $63 |
| Operating Income | $506 | $798 | $2,470 | $252 | -$1,777 |
| Net Income | $376 | $124 | $2,690 | $1,573 | -$1,179 |
Over the past five years, Albemarle’s income statement displays marked variability across key performance metrics. Revenue grew steadily from US$3.13 billion in 2020 to a peak of US$9.62 billion in 2023, with a dramatic surge observed in 2022 when revenue more than doubled to US$7.32 billion. This robust revenue increase in 2022 also translated into improved gross profit and operating income, climbing to US$3.07 billion and US$2.47 billion, respectively, while net income surged to US$2.69 billion. However, 2021 saw a notable discrepancy where operating income improved considerably to US$798 million despite a marginal revenue uptick, yet net income fell sharply to US$124 million, signaling potential increases in non-operational expenses or other cost pressures. A significant year-over-year swing emerged between 2023 and 2024. In 2024, revenue dropped substantially to US$5.38 billion—a decline of approximately 44% from the previous year—coupled with a stark deterioration in profitability. Gross profit nearly evaporated to US$62.54 million, and operating income turned negative at –US$1.78 billion, while net income also plunged to –US$1.18 billion. Such drastic shifts, exceeding 20% changes, may be indicative of either volatile market conditions in the lithium and specialty chemicals sector or operational challenges including pricing pressures and rising costs. Overall, while the strong performance in 2022 underscores Albemarle’s capacity to generate substantial profits in favorable market conditions, the downturn in 2024 raises concerns about the sustainability of its financial health. These mixed results suggest that the company may need to address operational resilience and cost management to stabilize earnings in an inherently cyclical industry.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.